Hyris and Indena partner for on-site genomic identification of botanical species

Published: 3-May-2017

Indena holds preferential access, exclusive for the dietary supplement ingredient industry, to breakthrough genomic technology

Indena and Hyris have signed a cooperation agreement for the development of methods dedicated to the genomic identification of botanical species.

These are based on unique sets of reagents for specific DNA sequences (bKITs) and the use of bCUBE miniaturised, portable technology – a state-of-the-art device for the analysis of nucleic acids.

With this agreement, Indena will also acquire a minority shareholding position in Hyris and therefore hold preferential access to this technology in the botanical derivatives industry.

Hyris

The Hyris platform offers the capability to perform full genetic analysis of biological samples in any kind of setting.

It incorporates all the needed hardware, software and reagents and can be used as a fully portable testing laboratory to provide highly accurate results, reducing the time associated with traditional methods.

Every bCUBE is only 1.5kg and its design makes it portable and user friendly. It can be controlled by bAPP, a dedicated mobile app that provides a complete, intuitive, user-friendly interface:

bApp allows the user to:

  • Download the test protocol required for the desired analysis;
  • Check the reaction as it is happening;
  • Receive immediate diagnostic information on the sample being examined.

Insights

bCUBE is a miniaturised device for the analysis of nucleic acids. It allows user to run both temperature cycles and isothermal analysis, enabling a wide array of DNA and RNA detection methods such as qPCR and isothermal amplifications.

Multiwavelength signal acquisition, fast processing and wireless connectivity with its smartphone based control panel are all integrated. Hyris employs customised cartridges that can be used to analyse 9–32 samples in one run.

bKITs are reagent sets used to analyse a specific genetic sequence.

They can be used for the detection of a pathogen in a biological sample, the correct identification of the nature of the sample and a large number of other purposes.

bKITs are available for R&D and diagnostic purposes for the detection of a number of nucleic acid signatures of pathogens.

You may also like